Cardiomyopathy in Cats: Symptoms, Causes, Diagnosis & Treatment

What Is Cardiomyopathy in Cats?

Cardiomyopathy is a group of diseases that primarily affect the heart muscle (the myocardium), and it is the most common type of heart disease in cats. Unlike valve disorders or congenital defects, cardiomyopathy directly damages the muscle tissue that powers each heartbeat ^{[1, 2, 3]}.

Hypertrophic cardiomyopathy (HCM) alone is estimated to affect 10–15% of the general feline population, roughly 1 in 7 cats, making it the single most common cardiac condition seen in practice ^{[4, 5]}. The disease is sometimes called a "silent killer" because it can progress for years without obvious symptoms, and sudden death can be the first sign in some cats.

Veterinarians classify cardiomyopathy in two ways: by its structural appearance (called the phenotype) and by its underlying cause. Phenotypes include hypertrophic, dilated, restrictive, arrhythmogenic, and unclassified forms. Causes are either primary (idiopathic, meaning unknown origin, often genetic) or secondary (triggered by another disease, such as hyperthyroidism or high blood pressure) ^{[3, 6]}.

This article walks cat owners through the types, causes, warning signs, diagnostic approach, treatment options, home management, complications, prognosis, and end-of-life considerations for feline cardiomyopathy.

Types of Cardiomyopathy in Cats

The American College of Veterinary Internal Medicine (ACVIM) classifies cardiomyopathies by echocardiographic phenotype (the structural pattern seen on ultrasound), independent of the underlying cause ^[3]. Understanding the type your cat has helps guide treatment and prognosis.

Hypertrophic cardiomyopathy (HCM) is by far the most common. It is characterized by concentric thickening of the left ventricular muscle without chamber dilation. A wall thickness of 6 mm or more on echocardiogram is considered diagnostic, while a measurement of 5–6 mm falls into a gray zone that requires follow-up ^{[7, 2, 3]}. When the thickened muscle obstructs blood flow out of the heart, the condition is called hypertrophic obstructive cardiomyopathy (HOCM) and is often accompanied by systolic anterior motion (SAM) of the mitral valve ^[7].

Dilated cardiomyopathy (DCM) features an enlarged, weakened left ventricle with poor contractility (low fractional shortening, a measure of how much the heart squeezes with each beat). It is now uncommon in cats fed complete commercial diets but historically was linked to taurine deficiency ^{[6, 1]}.

Restrictive cardiomyopathy (RCM) has two forms. The endomyocardial form involves a scar inside the ventricle that can block blood flow and create an apical aneurysm (a bulging weak spot near the heart's tip). The myocardial form has normal wall thickness but severely enlarged atria and a "restrictive" filling pattern, meaning the stiff heart cannot relax properly to fill with blood ^{[6, 1]}.

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare form featuring severe dilation of the right atrium and ventricle, wall thinning, and dangerous ventricular arrhythmias (abnormal rapid heart rhythms originating in the lower chambers) ^[1].

Unclassified or non-specific phenotype is used when the structural changes do not fit into the other categories and should be described in detail ^[1].

Secondary cardiomyopathies develop in response to another disease, such as hyperthyroidism, systemic hypertension (high blood pressure), acromegaly (excess growth hormone), taurine deficiency, or infectious myocarditis (inflammation of the heart muscle, often viral) ^{[6, 3]}.

Warning Signs and Symptoms of Cardiomyopathy

Many cats with cardiomyopathy have no symptoms at all, and the disease is often discovered incidentally during a routine veterinary exam. Up to half of affected cats are diagnosed this way ^{[6, 4]}.

The earliest signs owners may notice are subtle: a heart murmur (a "whooshing" sound between heartbeats), a gallop rhythm (an extra heart sound, like a soft fourth beat), mild lethargy, slightly increased breathing rate at rest, or a tendency to hide or play less ^{[4, 7]}. In clinical studies, gallop rhythms are detected in about 13.6% of cats with HCM and murmurs of varying grades in many more, but a normal cardiac auscultation does not rule out disease ^[7].

When cardiomyopathy decompensates, the signs become dramatic and require immediate veterinary attention:

• Severe, labored breathing or open-mouth breathing (dyspnea)
• Sudden collapse or fainting
• Acute hindlimb paralysis with severe pain (a "saddle thrombus," where a blood clot blocks the aorta, the main artery leaving the heart)
• Sudden death, sometimes with no warning^{[4, 6, 5]}

Advanced disease may lead to congestive heart failure (CHF), in which fluid backs up into or around the lungs (pulmonary edema or pleural effusion). Affected cats breathe rapidly and shallowly ^[7]. Arterial thromboembolism (ATE) typically presents with the classic "5 Ps": Paralysis, Pain, Pulselessness, Pallor (pale or bluish pads), and Poikilothermia (cold limbs due to poor circulation) ^[6].

The clinical picture can vary by cardiomyopathy type. Cats with DCM often show lethargy and weakness from low cardiac output (the heart's inability to pump enough blood). Those with ARVC may have episodic collapse from ventricular tachycardia (dangerously fast heart rhythm). Cats with RCM often develop severe breathing difficulty and marked left atrial enlargement. Sudden death can be the first and only sign in HCM or ARVC ^{[5, 6]}.

Causes and Risk Factors

Primary HCM, the most common form, is largely genetic. Two well-documented mutations in the MYBPC3 gene (which encodes a protein essential for normal heart muscle contraction) have been identified in Maine Coons and Ragdolls, with an autosomal dominant inheritance pattern (a single copy of the mutated gene from either parent can cause disease) ^{[6, 2]}.

Several breeds are predisposed, including Maine Coon, Ragdoll, Persian, British Shorthair, Sphynx, Siberian, Norwegian Forest Cat, Scottish Fold, and others, though any breed, including mixed-breed cats, can be affected ^{[6, 7]}. Cats older than 6 years are at significantly higher risk, with a mean age at diagnosis of about 6 years. One study found cats aged 5–9 years had 5.7 times the odds of being diagnosed compared with seniors over 9 ^{[6, 8, 2]}. Males are more commonly affected than females ^[6].

Obesity is also a significant modifiable risk factor. Cats with a body condition score of 6 out of 9 or higher (the 9-point scale is a standard way veterinarians grade a cat's weight) had approximately 4 times the odds of developing HCM in one large study ^[8].

Secondary cardiomyopathies arise from treatable underlying conditions, including hyperthyroidism (overactive thyroid), systemic hypertension, acromegaly, taurine deficiency (causing DCM), and infectious myocarditis from agents such as feline coronavirus, FIV, Toxoplasma, or Bartonella ^{[6, 3]}.

In cats with pre-existing cardiomyopathy, stressful events such as anesthesia, surgery, intravenous fluids, corticosteroid injections, or even transport can trigger acute heart failure. Roughly half of cats diagnosed with CHF have a precipitating event ^[3].

Good news for owners: Cardiomyopathies caused by taurine deficiency or by conditions like hypertension or hyperthyroidism can often be reversed, or substantially improved, with appropriate treatment of the underlying disease.

How Cardiomyopathy Is Diagnosed

Diagnosis starts with a thorough history and physical examination, but up to half of cats with cardiomyopathy have no audible abnormality, so further testing is essential ^{[6, 1]}.

Echocardiography (cardiac ultrasound) is the gold standard. It directly visualizes the thickness of the heart muscle, chamber size, and function, allowing the cardiologist to classify the phenotype (HCM, DCM, RCM, ARVC, or unclassified) ^{[2, 7]}. Key findings by phenotype include:

• HCM: Concentric left ventricular hypertrophy with wall thickness ≥6 mm (5–6 mm is equivocal)
• DCM: Left ventricular dilation with reduced fractional shortening
• RCM: Normal ventricular size, marked left atrial enlargement, and restrictive filling pattern
• ARVC: Right-sided dilation, reduced wall thickness, systolic dysfunction, often with aneurysms

Thoracic radiographs (chest X-rays) help screen for cardiomegaly (an enlarged heart silhouette, seen in about 81.5% of HCM cats) and detect pulmonary edema or pleural effusion. A characteristic "Valentine heart" shape, with widening at the top of the heart and a pointed apex, suggests biatrial enlargement ^{[7, 6, 2]}.

Electrocardiography (ECG) records the heart's electrical activity and can detect arrhythmias. In one study of HCM cats, atrial premature complexes were found in about 30.9% and ventricular premature complexes in about 23.7% ^{[7, 6]}. For cats with fainting episodes or collapse, ambulatory monitoring (Holter monitors or implantable loop recorders) is recommended to catch intermittent arrhythmias.

Blood biomarkers are a useful supplement. NT-proBNP (a hormone released when the heart is strained) helps differentiate cardiac from respiratory causes of breathing difficulty. Cardiac troponin I (cTnI, a protein released when heart muscle is damaged) indicates the level of myocardial injury and can help stage disease ^{[1, 9]}.

Genetic testing for MYBPC3 mutations is available for Maine Coons and Ragdolls. It is most useful for breeding decisions, since a positive result cannot predict whether an individual cat will develop disease ^[1].

Secondary causes must be excluded by measuring blood pressure (to rule out hypertension), serum thyroxine (to rule out hyperthyroidism), and considering acromegaly or transient myocardial thickening in appropriate cases ^{[3, 2]}.

Once diagnosed, cats are staged using the ACVIM system:

Stage	Description
A	Predisposed (by breed or family history) but no structural disease
B1	Subclinical, low risk (normal or mildly enlarged atria)
B2	Subclinical, higher risk (moderate to severe left atrial enlargement)
C	Current or previous CHF or ATE
D	Refractory CHF (no longer responding to standard treatment)

^{[10, 1]}

What this means for your cat: The stage at diagnosis is one of the strongest predictors of outcome. Catching the disease at Stage B2, before symptoms appear, allows your veterinarian to start medications like clopidogrel to reduce clot risk and to monitor closely for early signs of heart failure, which can meaningfully extend a good-quality life ^{[6, 11]}.

Treatment Options for Cardiomyopathy

Treatment is stage-directed and individualised. The goals are to control clinical signs, slow progression, and prevent life-threatening complications. There is no cure for primary cardiomyopathy, but addressing reversible secondary causes (such as hyperthyroidism or hypertension) can resolve the heart changes entirely ^{[6, 1]}.

Stage A (predisposed cats): No cardiac medication is needed. Annual screening exams and avoiding breeding affected individuals are recommended ^[1].

Stage B1 (subclinical, low risk): Generally no medication. If severe dynamic left ventricular outflow tract obstruction (LVOTO, a narrowing that blocks blood flow leaving the heart) is present, a beta-blocker such as atenolol may be considered to slow heart rate and reduce obstruction ^[1].

Stage B2 (subclinical, higher risk): The antiplatelet drug clopidogrel is recommended if the left atrium is moderately to severely enlarged, to reduce the risk of ATE. Symptomatic arrhythmias may also be treated at this stage ^{[6, 1]}.

Acute CHF (Stage C crisis): Emergency treatment includes oxygen supplementation, injectable furosemide (a diuretic to remove fluid from the lungs), butorphanol for anxiety, and thoracocentesis (a needle inserted into the chest to drain fluid) if pleural effusion is present. Intravenous fluids are generally avoided because they can worsen fluid buildup, and beta-blockers should not be started until CHF is controlled ^[6].

Chronic CHF management (Stage C): Once stabilized, your cat will likely go home on oral medications. These typically include a daily diuretic (furosemide), an ACE inhibitor (such as enalapril or benazepril, which help relax blood vessels), and possibly pimobendan (a drug that strengthens heart contractions and dilates blood vessels) if systolic function is reduced. Clopidogrel is continued for clot prevention. Rhythm-control medications may be added if needed. Your veterinarian will determine the specific drugs and doses based on your cat's weight, bloodwork, and clinical picture ^{[6, 1]}.

Stage D (refractory CHF): When standard therapy no longer controls fluid buildup, the diuretic may be switched from furosemide to torsemide, pimobendan may be maximised, and anticoagulant strategy reassessed ^{[6, 1]}.

Arterial thromboembolism (ATE): Acute treatment focuses on pain control (typically opioid pain relief), anticoagulation (blood thinners such as heparin or a factor Xa inhibitor), and supportive care. Thrombolytics (clot-busting drugs) have not improved outcomes in studies. Euthanasia is a humane consideration for severe cases, especially those with multiple limbs affected, low body temperature, or concurrent CHF ^[1].

Type-specific options: Taurine supplementation can reverse DCM caused by taurine deficiency. Pimobendan is used for DCM with poor contractility. Beta-blockers help cats with severe dynamic obstruction. Cats with ventricular arrhythmias from ARVC may benefit from atenolol or sotalol.

New and Emerging Treatments for Cardiomyopathy

FDA-approved in 2025, Felycin-CA1 (sirolimus delayed-release tablets) is the first and only disease-modifying drug conditionally approved for cats with subclinical HCM (Stages B1–B2). This is a landmark development: until now, veterinarians had no therapy proven to slow the actual progression of HCM muscle thickening ^{[12, 5, 11]}.

How it works: Sirolimus (also known as rapamycin) is an mTOR inhibitor, a drug class that blocks a key cellular pathway driving muscle growth. By inhibiting mTOR, Felycin-CA1 appears to slow the thickening of the left ventricular wall ^[12].

What the evidence shows: In the placebo-controlled RAPACAT trial, cats receiving Felycin-CA1 showed a reduction in maximal LV wall thickness, while cats on placebo experienced an average increase of 0.94 mm ^{[11, 12]}.

Dosing and administration: Felycin-CA1 is given orally once a week, with weight-based dosing available in three tablet strengths. This makes home administration relatively simple ^[11].

Side effects and cautions: The most common adverse events relate to progression of HCM itself (arrhythmia, CHF, syncope), along with gastrointestinal upset (vomiting, diarrhea, lethargy) and liver enzyme elevations. It should not be used in cats with diabetes mellitus or pre-existing liver disease. Bloodwork should be monitored regularly ^[11].

Conditional approval status: The FDA granted conditional approval on the basis of a "reasonable expectation of effectiveness," with safety standards equivalent to full approval. Full approval requires the ongoing HALT Study, a larger, multisite, placebo-controlled trial enrolling about 300 cats to confirm long-term benefits on survival, event-free interval, and quality of life ^{[11, 5]}.

Other areas of active research include anti-fibrotic therapies (drugs that target scarring of the heart muscle), advanced echocardiographic deformation imaging (a technique that measures how the heart muscle twists and stretches), and gene-targeted treatments. None have yet reached clinical use.

Living With and Managing a Cat With Cardiomyopathy

Home monitoring is the single most valuable thing you can do as an owner. Counting your cat's sleeping respiratory rate (SRR) is simple, free, and can detect developing heart failure days before outward symptoms appear. Watch your cat's chest rise and fall while sleeping or deeply relaxed. The normal rate is fewer than 30 breaths per minute; a rate consistently above 30, or an upward trend over several days, warrants a call to your veterinarian ^{[4, 5]}.

Practical tips for daily management:

• Track sleep respiratory rate several times a week and keep a journal. Digital apps or simple spreadsheets work well.
• Minimise stress. Maintain a calm environment, avoid rough play, and handle your cat gently. Stress can trigger tachycardia (a dangerously fast heart rate), transient myocardial thickening, and acute decompensation ^{[6, 2]}.
• Feed a high-quality diet and maintain a healthy weight. Routine sodium restriction is generally not recommended unless specifically directed by a veterinary cardiologist, because overly low-salt diets can reduce palatability and contribute to muscle loss in heart patients.
• Never skip or stop medications without veterinary guidance. Diuretics, antiplatelet drugs, and heart medications must be given consistently.
• Schedule regular rechecks. Echocardiography every 6–12 months and blood pressure monitoring are standard for tracking disease progression.
• Know the emergency signs: Rapid breathing, open-mouth breathing, weakness, collapse, or sudden inability to use the hind limbs all require immediate veterinary attention ^[4].

Complications and Long-Term Risks

Congestive heart failure (CHF) is the most common complication. In one prospective study, approximately 24% of HCM cats developed CHF, which often requires emergency hospitalisation ^[13].

Arterial thromboembolism (ATE) occurs in about 11.6% of HCM cats and is a leading cause of death or euthanasia. A "saddle thrombus" lodges at the aortic bifurcation (where the main artery splits to supply the back legs), causing acute hindlimb paralysis and severe pain ^{[13, 7, 14]}.

Sudden cardiac death can occur without warning, reported in approximately 2.2% of HCM cats in prospective studies, often in cats with apparently stable disease ^[13].

Myocardial thinning in previously thickened segments is a worrisome sign of advanced disease and is associated with poor outcomes ^[2].

Risk factors for ATE include marked left atrial enlargement, spontaneous echocardiographic contrast (a "smoke-like" appearance of sluggish blood on ultrasound, suggesting it is prone to clotting), and reduced left atrial appendage flow velocity ^{[2, 15, 6]}.

Arrhythmias, including atrial fibrillation (an irregular, often very fast heart rhythm originating in the upper chambers) and ventricular tachycardia (a fast rhythm from the lower chambers), can precipitate collapse, worsen CHF, or cause sudden death, particularly in ARVC ^{[6, 1]}.

Prognosis and Life Expectancy

Prognosis varies widely by stage, phenotype, and complications. The encouraging news is that many cats with subclinical HCM live normal lifespans.

• Subclinical HCM (Stage B1): Median survival is often greater than 10 years, and many cats never progress to clinical disease ^{[13, 4]}.
• Moderate HCM with atrial enlargement: With appropriate management, survival is typically 3–5 years or longer ^[4].
• After CHF develops: Median survival drops to about 1.3 years ^{[13, 4]}.
• After ATE: Median survival is approximately 6 months, and many cats are euthanised at presentation due to severe pain and poor prognosis ^{[13, 4]}.

Cumulative cardiac death risk at 1, 5, and 10 years from diagnosis is approximately 6.7%, 22.8%, and 28.3%, respectively ^[13].

Older age is an independent negative prognostic factor, and cats homozygous (carrying two copies) for the MYBPC3 mutation experience earlier morbidity and mortality ^[3].

Outcomes vary by phenotype. DCM secondary to taurine deficiency is often reversible with supplementation; this is now rare in cats fed complete commercial diets but, when present, is a hopeful scenario. Survival in obstructive HCM (HOCM) is comparable to non-obstructive HCM. RCM and ARVC generally carry a more guarded prognosis ^[13].

Consistent home monitoring of sleeping respiratory rate and stress reduction can meaningfully extend both quality and length of life in cats with cardiomyopathy.^{[4, 5, 2]}

End-Stage Cardiomyopathy and End-of-Life Decisions

End-stage cardiomyopathy (Stage D) is characterised by congestive heart failure that no longer responds to maximal medical therapy, recurrent pleural effusion, and progressive decline.^[1]

Quality-of-life assessment is essential. Warning signs of poor quality include persistent breathing difficulty, refusal to eat, weakness, hiding, and inability to move comfortably. While no cardiomyopathy-specific validated scale exists, general feline quality-of-life tools (such as the HHHHHMM scale, which rates Hurt, Hunger, Hydration, Hygiene, Happiness, Mobility, and More good days than bad) can help owners track their cat's wellbeing over time.

Palliative care for end-stage disease focuses on comfort. This may include home oxygen therapy, pain control (especially for ATE), appetite stimulants, and close support from your veterinary team ^[15].

Euthanasia is a humane and loving option when suffering cannot be alleviated. Most cats with severe ATE are euthanised at presentation or shortly after due to the severity of pain and poor prognosis ^{[7, 1]}.

The value of early planning: Discussing advance care plans with your veterinarian before a crisis hits, including trigger points for euthanasia (such as repeated CHF hospitalisations or unmanageable pain), can spare you from making difficult decisions in an emergency waiting room. Setting a realistic budget of care also helps align medical decisions with financial realities.

Costs of Treating Cardiomyopathy in Cats

Costs vary widely by region, clinic, and case complexity. The figures below represent typical ranges in the United States and North America.

• Initial diagnosis: An echocardiogram with a cardiology consultation typically costs $400–$800. Repeat echocardiograms every 6–12 months add ongoing expense ^[4].
• Monthly medications: Common drugs include atenolol ($10–$30), diltiazem ($15–$40), clopidogrel ($15–$30), furosemide ($10–$20), and pimobendan ($30–$60). A typical monthly bill runs $30–$100 ^[4].
• Emergency treatment: Acute CHF or ATE crises can cost $1,500–$5,000 or more, depending on hospitalisation length and interventions required ^[4].
• Total lifetime cost: A cat with mild to moderate HCM may incur a few thousand dollars in routine care over its lifetime. Cats that develop CHF or ATE face potential costs exceeding $10,000 when hospitalisation and emergency treatment are factored in ^[4].

Pet insurance can offset these costs significantly. The best time to enrol is before a heart murmur is documented, as pre-existing conditions are typically excluded. Plans start at around $9/month in some markets ^[4].

Similar Conditions That Can Look Like Cardiomyopathy

Several conditions can mimic primary cardiomyopathy, making accurate diagnosis essential before starting long-term treatment.^{[3, 2]}

• Systemic hypertension can cause concentric left ventricular hypertrophy. Treating high blood pressure often reverses the heart changes ^{[3, 2]}.
• Hyperthyroidism increases heart rate and can cause reversible thickening. A simple blood test for thyroxine (T4) is diagnostic ^{[2, 3]}.
• Aortic stenosis (a congenital narrowing of the aortic valve) causes a loud murmur and pressure-overload hypertrophy, distinguished by echocardiography ^[2].
• Transient myocardial thickening (TMT) is an acute, often inflammatory process linked to recent stress such as anesthesia or vaccination. Wall thickness typically decreases with supportive care ^{[3, 2]}.
• Acromegaly (excess growth hormone from a pituitary tumor) causes generalised organ enlargement including the heart muscle, usually accompanied by insulin-resistant diabetes and characteristic facial features ^[3].
• Dehydration can cause a "pseudo-hypertrophy" appearance on echo that resolves with fluid therapy ^[2].
• Infectious myocarditis (from FIP, toxoplasmosis, bartonellosis) can present with similar myocardial changes and is identified through history, exposure, and specific testing ^[3].
• Taurine-deficiency DCM is now rare in cats fed complete commercial diets but can still occur, especially in cats fed unconventional diets. Diet history and exclusion of other causes help confirm it ^[6].

What We Still Don't Know: Gaps and Current Research

Despite major advances, important questions remain unanswered.

Predicting which cats will progress from subclinical HCM to CHF or ATE is still imperfect. Advanced echocardiographic techniques such as strain imaging (a precise measurement of how the heart muscle deforms during each beat) and speckle-tracking (a computerised method of detecting subtle movement in the heart wall) are under investigation to improve risk stratification ^[2].

Myocardial fibrosis (scarring of the heart muscle) is increasingly recognised as a driver of disease progression in HCM. Anti-fibrotic therapies are being explored, but no approved drugs are currently available for cats, and the exact role of fibrosis in progression remains to be fully defined ^[2].

Felycin-CA1's long-term impact on survival, quality of life, and event-free survival is still being studied in the HALT trial, which will provide the definitive effectiveness data needed for full FDA approval ^[5].

The genetic basis of HCM in non-pedigree cats and in breeds beyond Maine Coon and Ragdoll is largely unknown. In humans, more than 1,000 mutations in 11 genes are linked to HCM, but feline equivalents are poorly characterised ^[6].

Optimal thromboprophylaxis (clot-prevention) strategies lack robust veterinary clinical trials. Combined antiplatelet and anticoagulant therapy is extrapolated from human medicine, but no large feline studies have validated the best approach ^[6].

ARVC and unclassified cardiomyopathies have poorly documented natural histories, and prospective studies are needed to establish prognosis and treatment guidelines ^[1].

Connect with Other Cat Owners

When your cat has been diagnosed with cardiomyopathy, it can feel lonely and confusing — so hearing from other owners who have walked the same road, asked the same questions, and figured out the day-to-day realities of living with a heart cat can make a real difference. These Facebook groups are full of people sharing what they've learned:

• Sphynx Hearts: Feline HCM Support Group
• Cats with Blood Clots (saddle thrombus) FATE, HCM, CHF - heart cat support

These communities are run by fellow cat owners rather than veterinary professionals, so any medical tips or treatment experiences shared there are worth checking with your own vet — and it's a good idea to peek at a group's recent activity before joining to make sure it's still an active, supportive place for your situation.

❓ Frequently Asked Questions